Human group X secreted phospholipase A2 induces dendritic cell maturation through lipoprotein-dependent and -independent mechanisms

Atherosclerosis

Volumn 222, Issue 2, 2012, Pages 367-374

  Atout, Rajai ^a   Karabina, Sonia Athina ^a,b   Dollet, Sandra ^a,c   Carreras, Martine ^a,c   Payré, Christine ^d   André, Patrice ^a,c,e   Lambeau, Gérard ^d   Lotteau, Vincent ^a,c,e   Ninio, Ewa ^a   Perrin Cocon, Laure ^a,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ DE LYON   (France)

^d INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e CROIX ROUSSE HOSPITAL   (France)

Author keywords

Atherosclerosis; Dendritic cells; HGX sPLA2; Immune response; Inflammation; Lipid mediators; Phospholipolyzed LDL

Indexed keywords

FATTY ACID; INTERFERON; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; MEMBRANE PHOSPHOLIPID; PALMITIC ACID; PHOSPHOLIPASE A2 GROUP X; STEARIC ACID;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ATHEROSCLEROSIS; COCULTURE TECHNIQUES; DENDRITIC CELLS; FATTY ACIDS, NONESTERIFIED; GROUP X PHOSPHOLIPASES A2; HUMANS; HYDROLYSIS; INTERFERON-GAMMA; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; PHENOTYPE; PHOSPHATIDYLCHOLINES; TH1 CELLS;

EID: 84861349095     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.03.014     Document Type: Article

References (30)

1. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology 2006, 6:508-519.
2. Niessner A., Weyand C.M. Dendritic cells in atherosclerotic disease. Clinical Immunology 2010, 134:25-32.
3. Perrin-Cocon L., Coutant F., Agaugue S., et al. Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. The Journal of Immunology 2001, 167:3785-3791.
4. Coutant F., Agaugue S., Perrin-Cocon L., et al. Sensing environmental lipids by dendritic cell modulates its function. The Journal of Immunology 2004, 172:54-60.
5. Perrin-Cocon L., Agaugue S., Coutant F., et al. Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses. Vaccine 2006, 24:1254-1263.
6. Perrin-Cocon L., Diaz O., Carreras M., et al. High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation. Immunobiology 2011, 217:91-99.
7. Murakami M., Taketomi Y., Girard C., et al. Emerging roles of secreted phospholipase A2 enzymes: lessons from transgenic and knockout mice. Biochimie 2010, 92:561-582.
8. Lambeau G., Gelb M.H. Biochemistry and physiology of mammalian secreted phospholipases A2. The Annual Review of Biochemistry 2008, 77:495-520.
9. Perrin-Cocon L., Agaugue S., Coutant F., et al. Secretory phospholipase A2 induces dendritic cell maturation. European Journal of Immunology 2004, 34:2293-2302.
10. Ramoner R., Putz T., Gander H., et al. Dendritic-cell activation by secretory phospholipase A2. Blood 2005, 105:3583-3587.
11. Giannattasio G., Fujioka D., Xing W., et al. Group V secretory phospholipase A2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function. The Journal of Immunology 2010, 185:4430-4438.
12. Karabina S.A., Brocheriou I., Le Naour G., et al. Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function. FASEB Journal 2006, 20:2547-2549.
13. Kimura-Matsumoto M., Ishikawa Y., Komiyama K., et al. Expression of secretory phospholipase A2s in human atherosclerosis development. Atherosclerosis 2008, 196:81-91.
14. Hanasaki K., Yamada K., Yamamoto S., et al. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation. The Journal of Biological Chemistry 2002, 277:29116-29124.
15. Pruzanski W., Lambeau L., Lazdunsky M., et al. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A(2). Biochimica et Biophysica Acta 2005, 1736:38-50.
16. Yamamoto K., Isogai Y., Sato H., et al. Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics. Analytical and Bioanalytical Chemistry 2011, 400:1829-1842.
17. Jemel I., Li H., Oslund R.C., et al. Group X secreted phospholipase A2 proenzyme is matured by a furin-like protein convertase and release arachidonic acid inside of human HEK293 cells. The Journal of Biological Chemistry 2011, 286:36509-36521.
18. Gora S., Maouche S., Atout R., et al. Phospholipolyzed LDL induces an inflammatory response in endothelial cells through endoplasmic reticulum stress signaling. FASEB Journal 2010, 24:3284-3297.
19. Karabina S.A., Gora S., Atout R., Ninio E. Extracellular phospholipases in atherosclerosis. Biochimie 2010, 92:594-600.
20. Bezzine S., Koduri R.S., Valentin E., et al. Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. The Journal of Biological Chemistry 2000, 275:3179-3191.
21. Gora S., Lambeau G., Bollinger J.G., et al. The proinflammatory mediator platelet activating factor is an effective substrate for human group X secreted phospholipase A2. Biochimica et Biophysica Acta 2006, 1761:1093-1099.
22. Wiesner P., Leidl K., Boettcher A., et al. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. The Journal of Lipid Research 2009, 50:574-585.
23. Pruzanski W., Lambeau G., Lazdunski M., et al. Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2. Biochimica et Biophysica Acta 2007, 1771:5-19.
24. Oorni K., Kovanen P.T. Lipoprotein modification by secretory phospholipase A(2) enzymes contributes to the initiation and progression of atherosclerosis. Current Opinion in Lipidology 2009, 20:421-427.
25. Mallat Z., Benessiano J., Simon T., et al. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:1177-1183.
26. Mattson F.H., Grundy S.M. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. The Journal of Lipid Research 1985, 26:194-202.
27. Harizi H., Gualde N. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells. Tissue Antigens 2005, 65:507-514.
28. Randolph G.J., Inaba K., Robbiani D.F., et al. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999, 11:753-761.
29. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
30. Shridas P., Bailey W.M., Talbott K.R., et al. Group X secretory phospholipase A2 enhances TLR4 signaling in macrophages. The Journal of Immunology 2011, 187:482-489.